BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36149321)

  • 1. Efficacy and safety of miconazole muco-adhesive tablet versus itraconazole in oropharyngeal candidiasis: A randomized, multi-centered, double-blind, phase 3 trial.
    Wang Y; Zhou H; Wang W; Duan N; Luo Z; Chai H; Jiang L; Chen Q; Liu J; Hua H; Yan Z; Fan Y; Xu J; Guan X; Wang H; Lu H; Lun W; Fei W; Zhang T; Zhao J; Jia C; Kong H; Shen X; Liu Q; Wang W; Tang G
    Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36149321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: study of miconazole Lauriad® efficacy and safety (SMiLES).
    Vazquez JA; Patton LL; Epstein JB; Ramlachan P; Mitha I; Noveljic Z; Fourie J; Conway B; Lalla RV; Barasch A; Attali P;
    HIV Clin Trials; 2010; 11(4):186-96. PubMed ID: 20974574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets versus Itraconazole Capsules in the Treatment of Oral Candidiasis: An Open-Label, Randomized, Multicenter Trial.
    Yan Z; Liu X; Liu Y; Han Y; Lin M; Wang W; Guan X; Zhu S; Zhang H; Wang Q; Chou L; Zhu X; Hua H
    PLoS One; 2016; 11(12):e0167880. PubMed ID: 27977721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer.
    Bensadoun RJ; Daoud J; El Gueddari B; Bastit L; Gourmet R; Rosikon A; Allavena C; Céruse P; Calais G; Attali P
    Cancer; 2008 Jan; 112(1):204-11. PubMed ID: 18044772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis.
    Van Roey J; Haxaire M; Kamya M; Lwanga I; Katabira E
    J Acquir Immune Defic Syndr; 2004 Feb; 35(2):144-50. PubMed ID: 14722446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis.
    Fang J; Huang B; Ding Z
    J Prosthet Dent; 2021 Feb; 125(2):257-265. PubMed ID: 32165010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miconazole mucoadhesive tablets: a novel delivery system.
    Vazquez JA; Sobel JD
    Clin Infect Dis; 2012 May; 54(10):1480-4. PubMed ID: 22495075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
    Phillips P; De Beule K; Frechette G; Tchamouroff S; Vandercam B; Weitner L; Hoepelman A; Stingl G; Clotet B
    Clin Infect Dis; 1998 Jun; 26(6):1368-73. PubMed ID: 9636865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, placebo-controlled, phase 3 study of itraconazole for the treatment of onychomycosis.
    Maddin S; Quiring J; Bulger L
    J Drugs Dermatol; 2013 Jul; 12(7):758-63. PubMed ID: 23884486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
    de Repentigny L; Ratelle J
    Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miconazole mucoadhesive tablet for oropharyngeal candidiasis.
    Lalla RV; Bensadoun RJ
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):13-7. PubMed ID: 21171872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients.
    Linpiyawan R; Jittreprasert K; Sivayathorn A
    Int J Dermatol; 2000 Nov; 39(11):859-61. PubMed ID: 11123451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group.
    Hoppe JE
    Pediatr Infect Dis J; 1997 Mar; 16(3):288-93. PubMed ID: 9076817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of topical antifungal agents for oral candidiasis treatment: a systematic review and meta-analysis.
    Xiao Y; Yuan P; Sun Y; Xu Y; Deng X; Wang X; Liu R; Chen Q; Jiang L
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Mar; 133(3):282-291. PubMed ID: 34924340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
    Oude Lashof AM; De Bock R; Herbrecht R; de Pauw BE; Krcmery V; Aoun M; Akova M; Cohen J; Siffnerová H; Egyed M; Ellis M; Marinus A; Sylvester R; Kullberg BJ;
    Eur J Cancer; 2004 Jun; 40(9):1314-9. PubMed ID: 15177489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Miconazole in gingival muco-adhesive tablet (Loramyc 50mg)].
    Ben Slama L; Hasni W
    Rev Stomatol Chir Maxillofac; 2008 Jun; 109(3):197-200. PubMed ID: 18538809
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in aids patients.
    Queiroz-Telles F; Silva N; Carvalho MM; Alcântara AP; da Matta D; Barberino MG; Bartczak S; Colombo AL
    Braz J Infect Dis; 2001 Apr; 5(2):60-6. PubMed ID: 11493410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
    Barbaro G; Barbarini G; Di Lorenzo G
    Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.